As a matter of fact, comparing ERK2 with ERK1 in breast cancer cells invasiveness, ERK2, not ERK1, drives cells invasiveness migration by reducing the expression of motility suppressors genes [41]. The gene discussed is MAPK3; the disease is breast cancer.